Speaker illustration

Assistant Professor Evangelos Giannitsis

University hospital Heidelberg, Heidelberg (Germany)

Member of:

European Society of Cardiology

Assistant Professor of Medicine in Heidelberg. After gaining his medical degree from the University of Homburg, Prof. Giannitsis completed postgraduate training in internal medicine and cardiology at Lübeck University Hospital, Germany. Subsequently, he undertook a PhD in internal medicine before his current position in 2002. Prof. Giannitsis’s research interests focus on cardiac biomarkers, i.e. troponins, and their validation in the diagnosis of coronary syndromes, as well as cardiac MR imaging. He has been the Principal National Coordinator in many clinical trials in these fields including the PLATO trial, the ATLAS-TIMI 46 and ATLAS-TIMI 51 trials. He is a member of numerous professional societies including the European Society of Cardiology: He served as a member of the program committee for the ESC from 2010-2012, and he is a founder of the Chest Pain Unit initiative of the German Society of Cardiology and currently the Chair of the certification committee for Chest Pain Units.

Innovative digital solutions for optimal management of cardiovascular diseases

Event: ESC Congress 2022

Topic: Diagnostic Methods

Session type: Satellite Symposium

Thumbnail

Troponin and other biomarkers in acute coronary syndromes

Event: ESC Congress 2022

Topic: Biomarkers

Session type: Abstract Sessions

Thumbnail

Cardiac troponins and other biomarkers in acute coronary syndromes

Event: ESC CONGRESS 2019

Topic: Epidemiology, Prognosis, Outcome

Session type: Rapid Fire Abstracts

Thumbnail

From trial to treatment in vascular protection: which high risk patients benefit the most?

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Practical Tutorials

Thumbnail

Controversies in diagnostic strategies for chest pain patients

Event: Acute Cardiovascular Care 2019

Topic: Acute Coronary Syndromes

Session type: Debate Session

Thumbnail

This platform is supported by

logo Novo Nordisk